GMP 細胞庫服務的全球市場：按細胞類型、最終用戶、地區規模、份額、前景、機會分析（2022-2028 年）

預計在預測期內，罕見病研發資金的增加將推動全球 GMP 細胞庫服務市場的增長。此外，發展中國家生物技術部門的快速擴張以及政府促進生物技術產業的努力也有望在預測期內推動市場增長。

本報告探討了全球 GMP 細胞庫服務市場，並提供了有關市場前景、市場動態、市場分析、競爭格局等方面的全面信息。

目錄

第 1 章調查目標/先決條件

第二章市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
  • 市場細分：按細胞類型
  • 市場細分：按最終用戶
  • 市場細分：按地區
  • 連貫的機會圖 (COM)

第三章市場動態、監管和趨勢分析

• 市場動態
  • 促進因素
  • 抑制器
  • 市場機會
• 影響分析
• 主要亮點
• 產品發布
• PEST 分析
• 監管場景
• 併購

第 4 章全球 GMP 細胞庫服務市場：按細胞類型（100 萬美元）（2017-2028）

• 簡介
• 哺乳動物
• 微生物
• 昆蟲
• 酵母
• 鳥類
• 幹細胞
• 其他

第 5 章全球 GMP 細胞庫服務市場：按最終用戶（100 萬美元）（2017-2028 年）

• 簡介
• 生物製藥公司
• 合同製造組織

第 6 章全球 GMP 細胞庫服務市場：區域（100 萬美元）（2017-2028）

• 簡介
• 北美
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第7章競爭態勢

• 公司簡介
  • WuXi AppTec Group
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Merck KGaA
  • Lonza Group Ltd.
  • SGS Ltd.
  • ViruSure GmbH
  • Austrianova
  • Goodwin Biotechnology Inc.
  • Paragon Bioservices, Inc.

第8章 章節

GMP cell banking services is termed as the storing of cells of specific genome for the purpose of future use in a product or medicinal needs. Different types of cell lines stored in cell banks constitute of mammalian cells, microbial cells, insect cell lines, yeast cells, avian cells, and stem cells. Increasing funding for R&D in rare diseases is expected to boost growth of the global GMP cell banking services market over the forecast period. Furthermore, rapidly increasing biotechnology sector in developing countries along with increased government initiatives to promote biotechnology industry is also expected to propel the growth of the market during the forecast period.

Key features of the study:

This report provides in-depth analysis of the GMP Cell Banking Services market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players

It profiles key players in the global GMP Cell Banking Services market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include, WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global GMP Cell Banking Services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP Cell Banking Services market

Detailed Segmentation:

GMP Cell Banking Services Market, By Cell Type:

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

GMP Cell Banking Services Market, By End User:

Biopharmaceutical Companies

Contract Manufacturing Organizations

GMP Cell Banking Services Market, By Region:

North America

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

U.S.

Canada

Latin America

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

GCC

Israel

Rest of Middle East

Africa

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

South Africa

Central Africa

North Africa

Company Profiles

WuXi AppTec Group *

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Charles River Laboratories International, Inc.

Eurofins Scientific

Merck KGaA

Lonza Group Ltd.

SGS Ltd.

ViruSure GmbH

Austrianova

Goodwin Biotechnology Inc.

Paragon Bioservices, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Cell Type
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product launch
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global GMP Cell Banking Services Market, By Cell Type, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Microbial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Insect
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Yeast
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Avian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Stem Cell Type
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global GMP Cell Banking Services Market, By End User, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Contract Manufacturing Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global GMP Cell Banking Services Market, By Region, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of APAC
• Middle East
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

7. Competitive Landscape

• Company Profiles
  • WuXi AppTec Group
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Charles River Laboratories International, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Eurofins Scientific
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Merck KGaA
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Lonza Group Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • SGS Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • ViruSure GmbH
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Austrianova
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Goodwin Biotechnology Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Paragon Bioservices, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

8. Section

• References
• Research Methodology
• About us and Sales Contact